☆ 4.7 Article

1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients

JOURNAL OF PERSONALIZED MEDICINE (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac

Stefania Naccarato et al.

Summary: This study compared the adaptive planning and manual planning for SBRT treatment of prostate cancer. The study found that the automated planning (mCycle) performed better than manual planning in terms of target dose coverage and rectal dose sparing on the 1.5T MR-Linac. However, mCycle plans consumed slightly more delivery time and monitor units. This study provides a feasible solution for adaptive planning on the 1.5T MR-Linac.

ADVANCES IN RADIATION ONCOLOGY (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes

Filippo Alongi et al.

Summary: This study compared the dosimetric advantages and treatment feasibility of using and not using rectal spacers in patients undergoing 1.5T MR-guided prostate cancer SBRT. The results showed statistically significant dosimetric advantages in favor of the spacer group, improving target volume coverage, with no significant differences in PROMs between the two groups.

BRITISH JOURNAL OF RADIOLOGY (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results of outcome and toxicity

Gamze Ugurluer et al.

Summary: The study presented preliminary results on clinical utilization of MRI-guided adaptive radiotherapy for prostate cancer patients. Patients treated with ultra-hypofractionation showed good tolerance to acute toxicities and low risk of late toxicities.

BRITISH JOURNAL OF RADIOLOGY (2021)

添加到收藏夹

Article Oncology

Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial

Ting Martin Ma et al.

Summary: The MIRAGE trial is the first randomized trial comparing MRI-guided with standard CT-guided SBRT for localized PCa. The primary hypothesis is that MRI-guided SBRT will lead to an improvement in the cumulative incidence of acute grade >= 2 GU toxicity when compared to CT-guided SBRT. The pragmatic superiority design focused on an acute toxicity endpoint will allow an early comparison of the two technologies.

BMC CANCER (2021)

添加到收藏夹

Article Oncology

Toxicity at 1 Year After Stereotactic Body Radiation Therapy in 3 Fractions for Localized Prostate Cancer

Alessandro Magli et al.

Summary: The toxicity profile of prostate cancer stereotactic body radiation therapy (SBRT) in 3 fractions is acceptable at 12 months after treatment, with no persistent grade 2+ genitourinary toxicity. There is a strong association between bladder dose/volume metrics at planning and worsening of patient-reported outcomes at 12 months after treatment.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

添加到收藏夹

Review Oncology

MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer

Francesco Cuccia et al.

Summary: The biological features of prostate cancer with a low alpha beta ratio have led clinicians to consider higher doses per fraction. International clinical guidelines support moderate hypofractionated schedules, with recent data showing non-inferiority results for extreme hypofractionated schedules like five-fractions regimens. The introduction of MR-guided daily adaptive radiotherapy is a potential paradigm shift, with promising results reported in terms of tolerability and preliminary clinical outcomes.

CANCERS (2021)

添加到收藏夹

Article Oncology

ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology

Stefanie Corradini et al.

Summary: Online magnetic resonance-guided radiotherapy (oMRgRT) is a revolutionary application in image-guided radiation therapy, allowing for adaptive treatment planning and online imaging to improve targeting accuracy and avoid critical structures. The implementation of hybrid MR-linac systems presents new challenges and issues that need to be thoroughly explored before clinical treatments can begin.

RADIOTHERAPY AND ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Magnetic Resonance-guided Stereotactic Radiotherapy for Localized Prostate Cancer: Final Results on Patient-reported Outcomes of a Prospective Phase 2 Study

Shyama U. Tetar et al.

Summary: The study reported the health-related quality of life outcomes at 1 year following stereotactic MRgRT treatment for prostate cancer patients. Significant treatment effects on urinary and bowel symptoms were observed in the first 6 weeks post-treatment, with symptoms decreasing and returning to baseline values at 12 months. No grade >= 3 toxicity was reported.

EUROPEAN UROLOGY ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial

Kim C. de Vries et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

添加到收藏夹

Article Oncology

1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment

Filippo Alongi et al.

RADIATION ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy

Francesco Cuccia et al.

RADIATION ONCOLOGY (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session time

Ruggero Ruggieri et al.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2020)

添加到收藏夹

Review Oncology

MR-Guided Radiotherapy for Prostate Cancer

Boris R. Tocco et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI

Angela U. Pathmanathan et al.

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS (2019)

添加到收藏夹

Review Oncology

MR-guidance in clinical reality: current treatment challenges and future perspectives

S. Corradini et al.

RADIATION ONCOLOGY (2019)

添加到收藏夹

Article Oncology

A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results

Anna M. E. Bruynzeel et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

添加到收藏夹

Article Medicine, General & Internal

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark et al.

LANCET (2019)

添加到收藏夹

Article Oncology

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas H. Brand et al.

LANCET ONCOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer

Amar U. Kishan et al.

JAMA NETWORK OPEN (2019)

添加到收藏夹

Article Oncology

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer

Charles N. Catton et al.

JOURNAL OF CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Oncology

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

David Dearnaley et al.

LANCET ONCOLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

F. C. Hamdy et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.